Image credit: Jialun Zhu, Shuyu Lin, and Yichao Zhao (I²BL/UCLA)
Engineers at the UCLA Samueli School of Engineering and their colleagues at Stanford School of Medicine have demonstrated that drug levels inside the body can be tracked in real time using a custom smartwatch that analyzes the chemicals found in sweat. This wearable technology could be incorporated into a more personalized approach to medicine — where an ideal drug and dosages can be tailored to an individual.
A study detailing the research was published in Proceedings of the National Academy of Sciences.
In general, medications are prescribed with a ‘one-size-fits-all’ approach — drugs are designed and prescribed based on statistical averages of their effectiveness. There are guidelines for factors such as patients’ weight and age. But in addition to these basic differentiators, our body chemistry constantly changes — depending on what we eat and how much we’ve exercised. And on top of these dynamic factors, every individual’s genetic makeup is unique and hence responses to medications can vary. This affects how fast drugs are absorbed, take effect and get eliminated from an individual.
According to the researchers, current efforts to personalize the drug dosage rely heavily on repeated blood draws at the hospital. The samples are then sent out to be analyzed in central labs. These solutions are inconvenient, time-consuming, invasive and expensive. That is why they are only performed on a small subset of patients and on rare occasions.
“We wanted to create a wearable technology that can track the profile of medication inside the body continuously and non-invasively,” said study leader Sam Emaminejad, an assistant professor of electrical and computer engineering at UCLA. “This way, we can tailor the optimal dosage and timing of the intake for each individual. And using this personalization approach, we can improve the efficacy of the therapeutic treatments.”
Because of their small molecular sizes, many different kinds of drugs end up in sweat, where their concentrations closely reflect the drugs’ circulating levels. That’s why the researchers created a smartwatch, equipped with a sensor that analyzes the sampled tiny droplets of sweat.
The team’s experiment tracked the effect of acetaminophen, a common over-the-counter pain medication, on individuals over the period of a few hours. First, the researchers stimulated sweat glands on the wrist by applying a small electric current, the same technique that Emaminejad’s research group demonstrated in previous wearable technologies.
This allowed the researchers to detect changes in body chemistry, without needing subjects to work up a sweat by exercising. As different drugs each have their own unique electrochemical signature, the sensor can be designed to look for the level of a particular medication at any given time.
“This technology is a game-changer and a significant step forward for realizing personalized medicine,” said study co-author Ronald W. Davis, a professor of biochemistry and genetics at Stanford Medical School. “Emerging pharmacogenomic solutions, which allow us to select drugs based on the genetic makeup of individuals, have already shown to be useful in improving the efficacy of treatments. So, in combination with our wearable solution, which helps us to optimize the drug dosages for each individual, we can now truly personalize our approaches to pharmacotherapy.”
What makes this study significant is the ability to accurately detect a drug’s unique electrochemical signal, against the backdrop of signals from many other molecules that may be circulating in the body and in higher concentrations than the drug, said the study’s lead author Shuyu Lin, a UCLA doctoral student and member of Emaminejad’s Interconnected and Integrated Bioelectronics Lab (I²BL). Emaminejad added that the technology could be adapted to monitor medication adherence and drug abuse.
“This could be particularly important for individuals with mental health issues, where doctors prescribe them prolonged pharmacotherapy treatments,” he said. ” The patients could benefit from such easy-to-use, noninvasive monitoring tools, while doctors could see how the medication is doing in the patient.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Tracking medication levels
- Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at ...on April 10, 2021 at 5:33 am
VIP236 shows enhanced tumor targeting with robust antitumor activity across multiple xenograft models First-in-human studies on track for 1H 2022 PALO ALTO ... a novel small molecule drug conjugate ...
- Los Angeles Allergy Tracker: Brace For Pollen And Sneezingon April 9, 2021 at 1:36 pm
According to the pollen.com tracker, Los Angeles is currently experiencing medium to high levels of pollen ... Antihistamine: A medication that prevents symptoms such as congestion, sneezing ...
- Track and Trace Solutions Market Worth $ 7.46 Billion, Globally, by 2028 at 16.9% CAGR: Verified Market Research™on April 9, 2021 at 6:18 am
Drug counterfeiting is a major problem faced by pharmaceuticals and biopharmaceutical companies. Thus, companies are adopting track and trace solutions for ... Our 250 Analysts and SME’s offer a high ...
- Washington Allergy Tracker: Bracing For Pollen, Sneezing & Ruinon April 8, 2021 at 11:29 am
And those counts can fluctuate quickly: Wednesday allergy levels were medium-high and they're set to be high on Friday as well. However, pollen.com’s allergy tracker can be used ... Antihistamine: A ...
- Immutep up 11pc on US fast-track designation for lead drug candidateon April 7, 2021 at 7:45 pm
Immutep shares hit their highest level after the Sydney biotech's lead product candidate was green-lit for possible early regulatory approval in the US.
Go deeper with Google Headlines on:
Tracking medication levels
Go deeper with Bing News on:
Personalized drug dosage
- Medication Adherence Market Expanding Due to Specialized Market Entrantson April 9, 2021 at 6:23 am
Medication adherence refers to patients taking the medication prescribed by their healthcare providers at the correct dosage and timing. Medication nonadherence is an important public health concern, ...
- A digital nervous system aiming toward personalized IoT healthcareon April 8, 2021 at 3:51 am
On the hardware side, IoT includes sensors and actuators, placed on and inside items, systems, animals, and humans, that together form wired or wireless networks connected to information technology ...
- EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect'on April 7, 2021 at 1:47 pm
The condition is similar to one seen in people who have been treated with the drug heparin, a blood thinner used to prevent ... But Italy also said there was no evidence to stop people having a second ...
- Prefilled Syringes Market Size to Grow at a CAGR of 8.3% During the Forecast Period 2021-2026on April 7, 2021 at 8:58 am
Prefilled syringes are single-dose pack of vaccine that includes needle ... and PFS are helping pharmaceutical companies in biotech industry to deliver personalized drugs formulated for smaller ...
- Compounding Pharmacies Market Hit 14,995.1 million by 2028 and to grow at a CAGR of 6.1% - US Compounding, Vertisis Custom Pharmacy, Fagronon April 6, 2021 at 10:42 pm
The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028. The ...